Skip to main content
NIH
Forecasted

RFA-DK-26-314

Single Source for Establishing Pilot/Opportunity program for AI Models to Accelerate Diabetes Research (U24- Clinical Trials not allowed)

Summary

AI-generated

Briefing: AI Foundation Models for Diabetes Heterogeneity

Diabetes presents a major public health challenge characterized by substantial disease heterogeneity—variation in disease mechanisms, progression, and treatment response across individuals—that demands personalized approaches to prevention, diagnosis, treatment, and prognosis. The diabetes research field has accumulated large, complex datasets and extensive prior knowledge, yet extracting actionable predictive signals remains difficult due to limited data science expertise and the absence of diabetes-specific artificial intelligence (AI) tools and foundation models. This pilot program seeks multidisciplinary teams combining diabetes researchers and data science experts to develop AI foundation models tailored to diabetes, validate them against key research questions in disease heterogeneity, and create practical use cases demonstrating their research acceleration potential. The initiative spans computational biology, clinical informatics, and machine learning, aiming to integrate AI expertise into the diabetes research workforce and deliver accessible models and tools for the broader community.

Who can apply: Multidisciplinary teams including both diabetes domain experts and data science/AI experts; merit-based peer review required.

Funding & project length: Not stated.

Award / mechanism: Pilot funding program.

Key dates: Not stated.

Best fit for: Researchers in endocrinology, metabolic disease, and biomedical data science using machine learning, predictive modeling, and foundation models to address diabetes heterogeneity and personalized medicine.

Insights (5)

Multidisciplinary team composition is non-negotiable; diabetes-only expertise insufficient

collaboration

The initiative explicitly requires teams that include both diabetes experts AND data science/AI experts. A diabetes researcher without embedded data science collaborators will be at a structural disadvantage. This is not a preference but a core program design principle, making team assembly a critical success factor before submission.

Foundation model development positions applicants as field infrastructure builders

strategic fit

The program prioritizes creating reusable AI foundation models for diabetes heterogeneity that the broader community can adopt. Applicants with experience in model generalization, transfer learning, or building tools for non-specialist users will be more competitive than those proposing single-use predictive models. This positions successful applicants as workforce developers, not just researchers.

Pilot program structure favors established diabetes researchers with new AI partnerships

career stage

As a pilot initiative, this likely targets researchers with credibility in diabetes science who are adding AI capability, rather than early-stage investigators. The emphasis on 'integrating new AI experts into the diabetes research workforce' suggests the program values diabetes domain knowledge as the anchor, with AI as the new addition—advantaging mid-to-senior researchers over ESI.

Diabetes heterogeneity focus requires evidence of prior work on disease subtypes or phenotypes

strategic fit

The program centers on addressing heterogeneity through AI—not general diabetes research. Applicants with prior publications or preliminary data on diabetes subtypes, endotypes, or phenotypic stratification will demonstrate stronger fit than those proposing generic predictive models. This specificity narrows the competitive pool but rewards focused expertise.

Pilot program scope suggests limited awards; high bar for meritorious applications

competition

The text emphasizes 'pilot funding program' and 'only meritorious applications will be considered'—language indicating selective, not broad, funding. Combined with the requirement for multidisciplinary teams and foundation model development (high technical bar), expect intense competition among well-resourced institutions with both diabetes and AI capacity.

Key Facts

Deadline

Posted

Thu, September 25, 2025

Keywords

diabetes heterogeneity
artificial intelligence
machine learning
foundation models
data science
personalized medicine
disease prevention
disease diagnosis
disease prognosis
predictive modeling
data integration
multidisciplinary research
computational biology
biomedical informatics

Research Areas

NIH Institute
Diabetes & Digestive & KidneyNIDDK
OpenAlex
Life SciencesD1Physical SciencesD3Health SciencesD4
Fields
Biochemistry, Genetics & Molecular BiologyF13Computer ScienceF17MathematicsF26MedicineF27Pharmacology, Toxicology & PharmaceuticsF30
Subfields
Artificial IntelligenceS1702Computational Theory & MathematicsS1703Numerical AnalysisS2612Statistics & ProbabilityS2613Endocrinology, Diabetes & MetabolismS2712Health InformaticsS2718
Topics
Neural Networks and ApplicationsT10320Diabetes Treatment and ManagementT10401Diabetes Management and ResearchT10560Advanced Clustering Algorithms ResearchT10637Diabetes Management and EducationT10793Natural Antidiabetic Agents StudiesT11140Diabetic Foot Ulcer Assessment and ManagementT11227Bayesian Modeling and Causal InferenceT11303+12 more
MeSH
DiseasesC
Nutritional & Metabolic DiseasesC18Endocrine System DiseasesC19
Analytical/Diagnostic/Therapeutic TechniquesE
DiagnosisE01TherapeuticsE02Investigative TechniquesE05
Phenomena & ProcessesG
MetabolismG03Genetic PhenomenaG05
Disciplines & OccupationsH
Natural Science DisciplinesH01Health OccupationsH02
Information ScienceL
Information ScienceL01
Health CareN
Health Care EconomicsN03Health Care Quality & EvaluationN05Environment & Public HealthN06
ANZSRC FoR
Biomedical & Clinical Sciences32
Medical Biochemistry & Metabolomics3205Oncology & Carcinogenesis3211
Health Sciences42
Public Health4206
Information & Computing46
Applied Computing4601Artificial Intelligence4602Data Management & Data Science4605Machine Learning4611
Mathematical Sciences49
Statistics4905

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About